Evidence map›Paper›PMID 40883418›Full record

ArticleScientific reports2025

ADAPT-3D:accelerated deep adaptable processing of tissue for 3-dimensional fluorescence tissue imaging for research and clinical settings.

Daniel D Lee, Kevin A Telfer, Deanna L Davis, Leon C D Smyth, Rahul Ravindran, Rafael S Czepielewski, Christopher G Huckstep, Siling Du, Kento Kurashima, Ajay K Jain and 3 more

Erratum issuedAbstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Daniel D Lee *Department of Pathology & Immunology, Washington University School of Medicine, St Louis, MO, USA. ldaniel@wustl.edu.
Kevin A Telfer *Department of Pathology & Immunology, Washington University School of Medicine, St Louis, MO, USA.
Deanna L DavisDepartment of Pathology & Immunology, Washington University School of Medicine, St Louis, MO, USA.
Leon C D SmythDepartment of Pathology & Immunology, Washington University School of Medicine, St Louis, MO, USA.
Rahul RavindranDepartment of Pathology & Immunology, Washington University School of Medicine, St Louis, MO, USA.
Rafael S CzepielewskiDepartment of Pathology & Immunology, Washington University School of Medicine, St Louis, MO, USA.
Christopher G HuckstepDepartment of Pathology & Immunology, Washington University School of Medicine, St Louis, MO, USA.
Siling DuDepartment of Pathology & Immunology, Washington University School of Medicine, St Louis, MO, USA.
Kento KurashimaDepartment of Pediatrics, Saint Louis University, Saint Louis, MO, USA.
Ajay K JainDepartment of Pediatrics, Saint Louis University, Saint Louis, MO, USA.
Jonathan KipnisDepartment of Pathology & Immunology, Washington University School of Medicine, St Louis, MO, USA.
Bernd H ZinselmeyerDepartment of Pathology & Immunology, Washington University School of Medicine, St Louis, MO, USA. bzinselmeyer@wustl.edu.
Gwendalyn J RandolphDepartment of Pathology & Immunology, Washington University School of Medicine, St Louis, MO, USA. gjrandolph@wustl.edu.

Funding

Washington University DDRCC Supplemental Equipment RequestP30DK052574 · NIDDK · WASHINGTON UNIVERSITY · PI Jeffrey Wade Brown · 2000 to 2026
$30.8M
The protein tyrosine kinase SYK drives innate immune responses against Alzheimer's DiseaseP01AG078106 · NIA · WASHINGTON UNIVERSITY · PI MARCO COLONNA · 2022 to 2026
$18.4M
PRINCIPLES IN CARDIVASCULAR RESEARCH TRAINING PROGRAMT32HL007081 · NHLBI · WASHINGTON UNIVERSITY · PI Abhinav Diwan, Karen Ellen Joynt Maddox · 1985 to 2026
$10.6M
DIFFERENTIATION AND FUNCTION OF MONOCYTES AND MACROPHAGESR37AI049653 · NIAID · WASHINGTON UNIVERSITY · PI RANDOLPH, GWENDALYN J · 2016 to 2025
$4.3M
Defining the lymphatic basis of protein losing enteropathy after Fontan palliation or inflammatory gut diseaseDP1DK130660 · NIDDK · WASHINGTON UNIVERSITY · PI RANDOLPH, GWENDALYN J · 2021 to 2025
$3.8M
Mechanisms that alter lymphatic transport in inflammatory bowel diseaseR01AI168044 · NIAID · WASHINGTON UNIVERSITY · PI Gwendalyn J Randolph · 2022 to 2026
$2.8M
Gut region-specific mechanisms that limit dissemination of microbial signals from the intestineU01AI163064 · NIAID · WASHINGTON UNIVERSITY · PI RANDOLPH, GWENDALYN J · 2021 to 2025
$2.2M
Crohn's and Colitis Foundation 938100National Institute of Aging PO1AG078106National Institute of Allergy and Infectious Diseases U01AI163064NHLBI NIH HHS T32 HL007081NIAID NIH HHS R01 AI168044NIAID NIH HHS R37 AI049653NIAID NIH HHS U01 AI163064NIA NIH HHS P01 AG078106NIDDK NIH HHS DP1 DK130660NIDDK NIH HHS DP1DK130660NIDDK NIH HHS P30 DK052574
6 · The paper itself

Abstract

Light sheet microscopy and preparative clearing methods that improve light penetration in 3D tissues have revolutionized imaging in biomedical research. Here we present ADAPT-3D, a streamlined 3-step approach to turn tissues optically transparent while preserving tissue architecture with the versatility to handle diverse tissue sizes and types across species. Unlike extensive lipid removal utilized by existing protocols, ADAPT-3D only partially removes lipids to preserve cell membranes, yet the non-toxic aqueous refractive indexing solution still rapidly turns tissues transparent while preserving the fluorescence of endogenous and antibody conjugated fluorophores. ADAPT-3D prepares whole mouse brains for light sheet microscopy in a 4-hour refractive indexing step after less than 4 days of preprocessing without changing their size. By maintaining tissue size, ADAPT-3D clears 1-mm thick brain slices in under 24 h without causing damage and facilitates a 3D section-like view of the meandering choroid plexus. We applied ADAPT-3D to overcome challenges of whole mouse skull clearing and visualized the undisturbed brain borders including specialized skull channels after just 8 days of tissue preparation. ADAPT-3D also had utility in clearing and immunolabeling human intestinal tissues in about 5 days. Overall, ADAPT-3D provides a high-speed, non-shrinking, and fluorescence-preserving workflow for 3D imaging that bridges section-based and whole-organ studies, offering new opportunities for biological discovery.

Indexed as

BrainImaging, Three-DimensionalOptical ImagingAnimalsHumansMiceMicroscopy, Fluorescence

Identifiers

PMID40883418
PMCPMC12397274

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.